Sign in

CIK 0001649094 · Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464233385
Phone
650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
  1. 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,204 shares (to pay taxes)
  2. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 2,759 shares (to pay taxes)
  3. 4 Shares withheld for taxes PRESIDENT AND CFO gave up 2,890 shares (to pay taxes)
  4. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 7,356 shares (to pay taxes)
  5. 4 Shares withheld for taxes SVP, FINANCE gave up 567 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,538 shares (to pay taxes)
  7. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 4,286 shares (to pay taxes)
  8. 4 Shares withheld for taxes PRESIDENT AND CFO gave up 5,080 shares (to pay taxes)
  9. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 10,840 shares (to pay taxes)
  10. 4 Grant or award SVP, FINANCE acquired 2,810 shares (grant or award)
  11. 4 Grant or award Director acquired 1,148 shares (grant or award)
  12. 4 Grant or award Director acquired 3,041 shares (grant or award)
  13. 4 Grant or award Director acquired 3,041 shares (grant or award)
  14. 4 Grant or award Director acquired 3,041 shares (grant or award)
  15. 4 Grant or award Director acquired 3,041 shares (grant or award)
  16. 4 Grant or award Director acquired 3,041 shares (grant or award)
  17. 4 Grant or award Director acquired 3,041 shares (grant or award)
  18. 4 Grant or award Director acquired 3,041 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 4 of 22 · 421 filings